Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001093151 | SCV001249995 | uncertain significance | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002482166 | SCV002777132 | uncertain significance | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-07-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004031995 | SCV004943169 | uncertain significance | Inborn genetic diseases | 2024-01-04 | criteria provided, single submitter | clinical testing | The c.8078C>T (p.P2693L) alteration is located in exon 51 (coding exon 51) of the RYR1 gene. This alteration results from a C to T substitution at nucleotide position 8078, causing the proline (P) at amino acid position 2693 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |